FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to ytterbium complex of 2,4-dimethoxyhematoporphyrin IX dipostassium salt of formula: 
.
EFFECT: producing a low-toxic compound used as a fluorescent tag for early cancer diagnosis, and having a relatively high lifetime level and luminescence intensity in long-wavelength infrared, as well as good water-solubility.
1 ex, 1 tbl, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| NANOCOMPOSITION FOR FLUORESCENT DIAGNOSIS OF MALIGNANT TUMOURS | 2014 |
|
RU2578976C2 |
| PHARMACEUTICAL COMPOSITION FOR FLUORESCENT DIAGNOSTICS OF PATHOLOGICAL CHANGES IN SKIN AND MUCOUS MEMBRANES | 2016 |
|
RU2617045C1 |
| YTTERBIUM TETRAPYRAZOLYL PORPHYRIN COMPLEXES AS FLUORESCENT TAGS TO DIAGNOSE MALIGNANT GROWTHS | 2008 |
|
RU2372099C1 |
| NANOCOMPOSITES FOR MAGNETOLUMINESCENT THERANOSTICS OF NEOPLASMS | 2021 |
|
RU2766513C1 |
| METHOD OF PRODUCING A DIPOTASSIUM SALT OF THE 2,4-DI(α-METHOXYETHYL)DEUTEROPORPHYRIN IX ACETYLACETONATE YTTERBIUM COMPLEX | 2019 |
|
RU2697418C1 |
| COMPOSITE NANOPARTICLES FOR PHOTODYNAMIC DIAGNOSIS | 2011 |
|
RU2463074C1 |
| METHOD OF PRODUCING BORATED PORPHYRINS | 2013 |
|
RU2551539C2 |
| DEVICE FOR LUMINISCENT DIAGNOSTICS OF NEOPLASMS | 2012 |
|
RU2483678C1 |
| METHOD FOR INVESTIGATING TISSUE MALIGNANCY PROCESS IN EXPERIMENTAL ANIMALS | 1988 |
|
SU1621720A1 |
| YTTERBIUM COMPLEXES OF PORPHYRINES AS LUMINESCENT AGENTS FOR DIAGNOSTICS OF MALIGNANT TUMORS | 1985 |
|
SU1340087A1 |
